GLOBAL CABAZITAXEL MARKET 2019 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2024


Report ID : RNR-264800 Category : Pharma Healthcare Published Date : Apr-19
Publisher : Research-N-Reports Pages : 123 Format : PDF

Avail 15% Discount, Use RNR15 Coupon Code.
T&C*

Cabazitaxel (previously XRP-6258, trade name Jevtana) is a semi-synthetic derivative of a natural taxoid. It was developed by Sanofi-Aventis and was approved by the U.S. FDA for the treatment of hormone-refractory prostate cancer on June 17, 2010. It is a microtubule inhibitor, and the fourth taxane to be approved as a cancer therapy.

Scope of the Report:
Global cabazitaxel production regions are mainly distributed in USA and Europe. There is no doubt that USA is the largest production region in the world. In the future, we predict that there will be more and more cabazitaxel suppliers as soon as Sanofi?s Cabazitaxel patent expired. By 2024, global production will be 1427.4 Kg. 
Currently, there are four major cabazitaxel API suppliers globally, including Sanofi, Tapi Teva, Fuan Pharmaceutical Group and Fujian Yewpark Biological etc. Sanofi is the global leader in this industry. According to our research, Sanofi had provided 845.8 Kg cabazitaxel API in 2017, which account for 95.32% of global market.
The worldwide market for Cabazitaxel is expected to grow at a CAGR of roughly 5.4% over the next five years, will reach 230 million US$ in 2024, from 170 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Cabazitaxel in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
- Sanofi
- Tapi Teva
- Fuan Pharmaceutical Group
- Fujian Yewpark Biological

Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
- Type I
- Type II

Market Segment by Applications, can be divided into
- Age Below 65
- Age Above 65

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cabazitaxel product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Cabazitaxel, with price, sales, revenue and global market share of Cabazitaxel in 2017 and 2018.
Chapter 3, the Cabazitaxel competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cabazitaxel breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Cabazitaxel market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Cabazitaxel sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents

1 Market Overview
1.1 Cabazitaxel Introduction
1.2 Market Analysis by Type
1.2.1 Type I
1.2.2 Type II
1.3 Market Analysis by Applications
1.3.1 Age Below 65
1.3.2 Age Above 65
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Business Overview
2.1.2 Cabazitaxel Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Sanofi Cabazitaxel Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Tapi Teva
2.2.1 Business Overview
2.2.2 Cabazitaxel Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Tapi Teva Cabazitaxel Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Fuan Pharmaceutical Group
2.3.1 Business Overview
2.3.2 Cabazitaxel Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Fuan Pharmaceutical Group Cabazitaxel Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Fujian Yewpark Biological
2.4.1 Business Overview
2.4.2 Cabazitaxel Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Fujian Yewpark Biological Cabazitaxel Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Cabazitaxel Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Cabazitaxel Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Cabazitaxel Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Cabazitaxel Manufacturer Market Share in 2018
3.3.2 Top 6 Cabazitaxel Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Cabazitaxel Market Analysis by Regions
4.1 Global Cabazitaxel Sales, Revenue and Market Share by Regions
4.1.1 Global Cabazitaxel Sales and Market Share by Regions (2014-2019)
4.1.2 Global Cabazitaxel Revenue and Market Share by Regions (2014-2019)
4.2 North America Cabazitaxel Sales and Growth Rate (2014-2019)
4.3 Europe Cabazitaxel Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Cabazitaxel Sales and Growth Rate (2014-2019)
4.5 South America Cabazitaxel Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Cabazitaxel Sales and Growth Rate (2014-2019)
5 North America Cabazitaxel by Country
5.1 North America Cabazitaxel Sales, Revenue and Market Share by Country
5.1.1 North America Cabazitaxel Sales and Market Share by Country (2014-2019)
5.1.2 North America Cabazitaxel Revenue and Market Share by Country (2014-2019)
5.2 United States Cabazitaxel Sales and Growth Rate (2014-2019)
5.3 Canada Cabazitaxel Sales and Growth Rate (2014-2019)
5.4 Mexico Cabazitaxel Sales and Growth Rate (2014-2019)
6 Europe Cabazitaxel by Country
6.1 Europe Cabazitaxel Sales, Revenue and Market Share by Country
6.1.1 Europe Cabazitaxel Sales and Market Share by Country (2014-2019)
6.1.2 Europe Cabazitaxel Revenue and Market Share by Country (2014-2019)
6.2 Germany Cabazitaxel Sales and Growth Rate (2014-2019)
6.3 UK Cabazitaxel Sales and Growth Rate (2014-2019)
6.4 France Cabazitaxel Sales and Growth Rate (2014-2019)
6.5 Russia Cabazitaxel Sales and Growth Rate (2014-2019)
6.6 Italy Cabazitaxel Sales and Growth Rate (2014-2019)
7 Asia-Pacific Cabazitaxel by Country
7.1 Asia-Pacific Cabazitaxel Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Cabazitaxel Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Cabazitaxel Revenue and Market Share by Country (2014-2019)
7.2 China Cabazitaxel Sales and Growth Rate (2014-2019)
7.3 Japan Cabazitaxel Sales and Growth Rate (2014-2019)
7.4 Korea Cabazitaxel Sales and Growth Rate (2014-2019)
7.5 India Cabazitaxel Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Cabazitaxel Sales and Growth Rate (2014-2019)
8 South America Cabazitaxel by Country
8.1 South America Cabazitaxel Sales, Revenue and Market Share by Country
8.1.1 South America Cabazitaxel Sales and Market Share by Country (2014-2019)
8.1.2 South America Cabazitaxel Revenue and Market Share by Country (2014-2019)
8.2 Brazil Cabazitaxel Sales and Growth Rate (2014-2019)
8.3 Argentina Cabazitaxel Sales and Growth Rate (2014-2019)
8.4 Colombia Cabazitaxel Sales and Growth Rate (2014-2019)
9 Middle East and Africa Cabazitaxel by Countries
9.1 Middle East and Africa Cabazitaxel Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Cabazitaxel Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Cabazitaxel Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Cabazitaxel Sales and Growth Rate (2014-2019)
9.3 Turkey Cabazitaxel Sales and Growth Rate (2014-2019)
9.4 Egypt Cabazitaxel Sales and Growth Rate (2014-2019)
9.5 Nigeria Cabazitaxel Sales and Growth Rate (2014-2019)
9.6 South Africa Cabazitaxel Sales and Growth Rate (2014-2019)
10 Global Cabazitaxel Market Segment by Type
10.1 Global Cabazitaxel Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Cabazitaxel Sales and Market Share by Type (2014-2019)
10.1.2 Global Cabazitaxel Revenue and Market Share by Type (2014-2019)
10.2 Type I Sales Growth and Price
10.2.1 Global Type I Sales Growth (2014-2019)
10.2.2 Global Type I Price (2014-2019)
10.3 Type II Sales Growth and Price
10.3.1 Global Type II Sales Growth (2014-2019)
10.3.2 Global Type II Price (2014-2019)
11 Global Cabazitaxel Market Segment by Application
11.1 Global Cabazitaxel Sales Market Share by Application (2014-2019)
11.2 Age Below 65 Sales Growth (2014-2019)
11.3 Age Above 65 Sales Growth (2014-2019)
12 Cabazitaxel Market Forecast (2019-2024)
12.1 Global Cabazitaxel Sales, Revenue and Growth Rate (2019-2024)
12.2 Cabazitaxel Market Forecast by Regions (2019-2024)
12.2.1 North America Cabazitaxel Market Forecast (2019-2024)
12.2.2 Europe Cabazitaxel Market Forecast (2019-2024)
12.2.3 Asia-Pacific Cabazitaxel Market Forecast (2019-2024)
12.2.4 South America Cabazitaxel Market Forecast (2019-2024)
12.2.5 Middle East and Africa Cabazitaxel Market Forecast (2019-2024)
12.3 Cabazitaxel Market Forecast by Type (2019-2024)
12.3.1 Global Cabazitaxel Sales Forecast by Type (2019-2024)
12.3.2 Global Cabazitaxel Market Share Forecast by Type (2019-2024)
12.4 Cabazitaxel Market Forecast by Application (2019-2024)
12.4.1 Global Cabazitaxel Sales Forecast by Application (2019-2024)
12.4.2 Global Cabazitaxel Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source